European Renal Association - European Dialysis And Transplant Association (era-edta)

PRAGUE, June 25, 2011 - - Lowering LDL cholesterol does not significantly slow down CKD progression The SHARP-study has shown that lowering LDL cholesterol with ezetimibe/simvastatinleads to a significant reduction in major atherosclerotic events among CKD-patients.